Skip to main content Skip to main menu
UF Health University of Florida
Division of Hematology & Oncology Department of Medicine in the College of Medicine
Marc S Zumberg

Marc S Zumberg, M.D.

Professor

Department: MD-HEMATOLOGY-ONCOLOGY
Business Phone: (352) 273-7832
Business Email: marc.zumberg@medicine.ufl.edu

On This Page

About Marc S Zumberg

Dr. Zumberg is recognized as an outstanding clinician-educator in the Division of Hematology/Oncology and the Department of Medicine.   He serves as Section Chief for benign hematology and holds various medical directorships.  He is chairman of the Shands Hospital Transfusion Committee.  He is noted as a key clinical faculty member in the Internal Medicine residency training program and the Division of Hematology/Oncology Fellowship Program.

Teaching Profile

Courses Taught

  1. BMS6631 – Hematology

    College of Medicine

  2. MDT7200 – Elect Top/Medicine

    College of Medicine

  3. MDC7200 – Medicine Clerkship

    College of Medicine

  4. MEL7948 – Elect Top/Medicine

    College of Medicine

  5. BMS6816 – Cancer Bio Clin Oncol

    College of Medicine

Board Certifications

  • Hematology
    American Board of Internal Medicine

Clinical Profile

Specialties

  • Cancer
  • Hematology

Areas of Interest

  • Anemia
  • Deep Vein Thrombosis
  • Hemochromatosis
  • Hereditary Hemorrhagic Telangiectasia
  • Immune Thrombocytopenic Purpura (ITP)
  • Sickle Cell Disease
  • Sickle Cell Test
  • Thrombocytopenia

Publications

Academic Articles

Grants

  1. A Phase 2b, multicenter, randomized, double-blind study of safety and efficacy of TAK-755 (rADAMTS13) with minimal to no plasma exchange (PEX) in the treatment of immune-mediated thrombotic thrombocytopenic purpura (iTTP)

    Active

    Role:
    Principal Investigator
    Funding:
    IQVIA Holdings via TAKEDA DEVELOPMENT CENTER AMERICAS INC

  2. Pomalidomide for the Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia – PATH

    Role:
    Principal Investigator
    Funding:
    CLEVELAND CLINIC FOU via NATL INST OF HLTH NHLBI

  3. Pomalidomide for the Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia – PATH

    Role:
    Principal Investigator
    Funding:
    CLEVELAND CLINIC FOU via NATL INST OF HLTH NHLBI

Education

  1. Fellowship

    University of Florida College of Medicine

  2. Residency

    University of Florida College of Medicine

  3. Medical Degree

    University of Michigan

Contact Details

Phones:
Business:
(352) 273-7832
Emails:
Business:
marc.zumberg@medicine.ufl.edu
Addresses:
Business Mailing:
PO Box 100278
 GAINESVILLE FL 32610
Business Street:
PO Box 100278
 GAINESVILLE FL 32610